Comparison of the effectiveness and safety of vaginal and sublingual low-dose misoprostol versus vaginal dinoprostone for labor ınduction: A retrospective cohort study

MakaleAçık ErişimScopus SJRQ1
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Background Labor induction is one of the most common obstetric interventions, yet the optimal pharmacological agent and route of administration remain subjects of ongoing debate. Prostaglandin analogs such as misoprostol and dinoprostone are widely used for cervical ripening and induction; however, evidence comparing their effectiveness and safety across different routes is still limited. Aim The primary purpose of the study is to evaluate the efficacy and safety of vaginal and sublingual misoprostol and vaginal dinoprostone pessary in labor induction. Materials and Methods Patients were divided into three groups based on the labor induction methods used. The first group included patients who received 25 µg vaginal misoprostol for labor induction, the second group included patients who received 25 µg sublingual misoprostol, and the third group included patients who received vaginal dinoprostone pessary. The primary outcome of the study was to evaluate vaginal delivery rates and time from induction to delivery of the fetus. The secondary outcomes of the study were to evaluate cesarean delivery rates, indications for cesarean delivery, first- and fifth-minute Apgar scores, birth weight, gender, amniotic fluid meconium contamination, and admission rates to the neonatal intensive care unit (NICU). The study data were collected from the hospital’s automation system and archives. All patients’ demographic and obstetric characteristics and maternal and fetal outcomes were recorded in a spreadsheet document (Microsoft Excel™), and statistical analyses were performed using the SPSS 28.0 program. Results Vaginal delivery rates were higher in the group where vaginal (86,5%) and sublingual misoprostol (85,3%) were applied, and cesarean delivery rates were higher in the group where vaginal dinoprostone pessary (31,6%) was applied (p=0.000). When the groups were compared according to the duration of labor, no difference was found in the vaginal (523.86±405,92) and sublingual misoprostol (560.15±438,00) groups, while the duration of labor was significantly higher in the dinoprostone pessary group (857.37±558,36) (p=0.000). Hyperstimulation (6.8%) (p=0.007) and admission rates to the neonatal intensive care unit (9.1%) (p=0.004) were higher in the dinoprostone group, and this difference was statistically significant. Conclusion According to the results of the study, low-dose vaginal or sublingual misoprostol was found to be more effective and safer than vaginal dinoprostone pessary in labor induction.

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/kostu/10396Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
0
WoS
0
OpenAlex
1
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorEminov, Elmin
dc.contributor.authorEminov, Ayşe
dc.date.accessioned2026-10-27T23:47:29.101674849Z
dc.date.available2026-10-27T23:47:29.101674849Z
dc.date.issued2025
dc.description.abstractBackground Labor induction is one of the most common obstetric interventions, yet the optimal pharmacological agent and route of administration remain subjects of ongoing debate. Prostaglandin analogs such as misoprostol and dinoprostone are widely used for cervical ripening and induction; however, evidence comparing their effectiveness and safety across different routes is still limited. Aim The primary purpose of the study is to evaluate the efficacy and safety of vaginal and sublingual misoprostol and vaginal dinoprostone pessary in labor induction. Materials and Methods Patients were divided into three groups based on the labor induction methods used. The first group included patients who received 25 µg vaginal misoprostol for labor induction, the second group included patients who received 25 µg sublingual misoprostol, and the third group included patients who received vaginal dinoprostone pessary. The primary outcome of the study was to evaluate vaginal delivery rates and time from induction to delivery of the fetus. The secondary outcomes of the study were to evaluate cesarean delivery rates, indications for cesarean delivery, first- and fifth-minute Apgar scores, birth weight, gender, amniotic fluid meconium contamination, and admission rates to the neonatal intensive care unit (NICU). The study data were collected from the hospital’s automation system and archives. All patients’ demographic and obstetric characteristics and maternal and fetal outcomes were recorded in a spreadsheet document (Microsoft Excel™), and statistical analyses were performed using the SPSS 28.0 program. Results Vaginal delivery rates were higher in the group where vaginal (86,5%) and sublingual misoprostol (85,3%) were applied, and cesarean delivery rates were higher in the group where vaginal dinoprostone pessary (31,6%) was applied (p=0.000). When the groups were compared according to the duration of labor, no difference was found in the vaginal (523.86±405,92) and sublingual misoprostol (560.15±438,00) groups, while the duration of labor was significantly higher in the dinoprostone pessary group (857.37±558,36) (p=0.000). Hyperstimulation (6.8%) (p=0.007) and admission rates to the neonatal intensive care unit (9.1%) (p=0.004) were higher in the dinoprostone group, and this difference was statistically significant. Conclusion According to the results of the study, low-dose vaginal or sublingual misoprostol was found to be more effective and safer than vaginal dinoprostone pessary in labor induction.
dc.identifier.articlenumbere0336025
dc.identifier.doi10.1371/journal.pone.0336025
dc.identifier.eissn1932-6203
dc.identifier.issn1932-6203
dc.identifier.issue10 OCTOBER
dc.identifier.pmcidPMC12578337
dc.identifier.pmid41171935
dc.identifier.scopus2-s2.0-105020645906
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/kostu/10396
dc.identifier.volume20
dc.identifier.wosWOS:001606904300007
dc.language.isoen
dc.publisherPublic Library of Science
dc.relation.ispartofPLOS ONE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject.classificationMultidisciplinary Sciences
dc.subject.classificationScience & Technology - Other Topics
dc.subject.otherAdministration, Intravaginal
dc.subject.otherAdministration, Sublingual
dc.subject.otherAdult
dc.subject.otherCesarean Section
dc.subject.otherDinoprostone
dc.subject.otherFemale
dc.subject.otherHumans
dc.subject.otherInfant, Newborn
dc.subject.otherLabor, Induced
dc.subject.otherMisoprostol
dc.subject.otherOxytocics
dc.subject.otherPregnancy
dc.subject.otherRetrospective Studies
dc.subject.otherYoung Adult
dc.subject.otheroxytocin
dc.subject.otherprostaglandin E2
dc.subject.otheroxytocic agent
dc.subject.otherabortion
dc.subject.otheramnion fluid
dc.subject.otheramniotomy
dc.subject.otherApgar score
dc.subject.otherArticle
dc.subject.otherbirth weight
dc.subject.othercardiotocography
dc.subject.otherchronic hypertension
dc.subject.otherclinical practice
dc.subject.othercohort analysis
dc.subject.othercomparative study
dc.subject.othercontamination
dc.subject.othercontrolled study
dc.subject.otherdemographics
dc.subject.otherdrug dose increase
dc.subject.otherdrug efficacy
dc.subject.otherdrug safety
dc.subject.otherfetus outcome
dc.subject.othergender
dc.subject.othergestational age
dc.subject.othergestational diabetes
dc.subject.otherhospital admission
dc.subject.otherhospitalization
dc.subject.otherhuman
dc.subject.otherhypertension
dc.subject.otherintrahepatic cholestasis of pregnancy
dc.subject.otherintrauterine growth retardation
dc.subject.otherlabor induction
dc.subject.otherlow drug dose
dc.subject.othermajor clinical study
dc.subject.othermaternal hypertension
dc.subject.othermeconium
dc.subject.otherneonatal intensive care unit
dc.subject.otherobstetric delivery
dc.subject.otheroligohydramnios
dc.subject.otheroutcome assessment
dc.subject.otherparity
dc.subject.otherpreeclampsia
dc.subject.otherpregnant woman
dc.subject.otherpreterm rupture of membranes
dc.subject.otherretrospective study
dc.subject.otheruterine cervix ripening
dc.subject.othervaginal delivery
dc.subject.otherintravaginal drug administration
dc.subject.othernewborn
dc.subject.otherprocedures
dc.subject.othersublingual drug administration
dc.titleComparison of the effectiveness and safety of vaginal and sublingual low-dose misoprostol versus vaginal dinoprostone for labor ınduction: A retrospective cohort study
dc.typeArticle
rdl.citation.openalex1
rdl.citation.scopus0
rdl.citation.wos0
rdl.departmentDepartment of Obstetrics and Gynecology, Faculty of Medicine, Duzce University, Duzce, Turkiye
rdl.departmentFaculty of Health Sciences, Kocaeli Health and Technology University, Kocaeli, Turkiye
rdl.oa.statusgold
rdl.oa.statusgreen
rdl.oa.urlhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0336025&type=printable
rdl.scopus.quartileQ1
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)